<i>MYCN</i>amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma
Diana Lau(Children's Cancer Institute Australia), Lesley J. Ashton(The University of Sydney), Samuele Gherardi(University of Bologna), Dilafruz Juraeva(Merck KGaA, Darmstadt (Germany)), Benedikt Brors(German Cancer Research Center), André Oberthuer, Matthias Fischer(University of Cologne), Michelle Haber(Cancer Clinic), Glenn M. Marshall(The University of Sydney), Giovanni Perini(University of Bologna), Jamie I. Fletcher(Cancer Institute of New South Wales), Claudia L. Flemming(Children's Cancer Institute Australia), Chengyuan Xue(Children's Cancer Institute Australia), Murray D. Norris(Cancer Clinic)
Cited by 18
Related Papers
Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations
|New England Journal of Medicine|2020|879
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
|Nature Genetics|2020|790
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
|Cell|2016|570
Accurate and efficient detection of gene fusions from RNA sequencing data
|Genome Research|2021|513